Home » Authors » Karl Thiel

Articles by Karl Thiel

FDA Oversteps its Bounds for Jazz Fibromyalgia Drug

Aug. 30, 2010

Eli Lilly CEO Provides Hints About Firm's Global Direction

Aug. 3, 2010

Human Genome Project Has Yet to Revolutionize Medicine

July 6, 2010

By Creating Impassable Pathway, Biosimilar Law Could be DOA

June 1, 2010

Scariest Thing About Myriad Case? Frightening Investors

May 10, 2010

Blocked Exits and Risk Aversion Mean Tough Times for Start-ups

March 8, 2010

Health Care Reform is Dead; Long Live Health Care Reform!

Feb. 1, 2010

The Year Ahead Offers Hope and a Whole Lot of Change

Jan. 4, 2010

Looking for Pharma Growth? Go East, Young Man, Go Eas

Dec. 9, 2009

Looking for Pharma Growth? Go East, Young Man, Go East

Dec. 7, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...